Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies

Enterome to Collaborate with Dana-Farber Cancer Institute on Microbiome Immunotherapies

Source: 
CP WIre
snippet: 

Enterome SA announced on 3/20/19 that is has entered into a research and development collaboration with Dana-Farber Cancer Institute (Boston, MA) to evaluate and develop gut microbiome-derived antigens as potential cancer immunotherapies.